Clinical Trial Results:
Estudio doble ciego, multicéntrico y aleatorizado de retirada de pacientes, que evalúa la eficacia y seguridad de Amibegron (350 mg dos veces al día) frente a placebo en la prevención de recaídas de ansiedad durante 1 año en pacientes con Trastorno de Ansiedad Generalizada que mejoraron tras 12 semanas de tratamiento abierto con Amibegron (350 mg dos veces al día).
Summary
|
|
EudraCT number |
2006-002253-71 |
Trial protocol |
ES DE HU IT |
Global completion date |
19 Sep 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Feb 2016
|
First version publication date |
28 Feb 2016
|
Other versions |
|
Summary report(s) |
LTE5894 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.